These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4041300)

  • 1. Use of inotropes and vasopressor agents in critically ill patients.
    Bangash MN; Kong ML; Pearse RM
    Br J Pharmacol; 2012 Apr; 165(7):2015-33. PubMed ID: 21740415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopexamine maintains mesenteric blood flow during systemic hypoxemia in the neonatal piglet.
    Thomas TV; Mace TP; Choe EU; Flint LM; Ferrara JJ
    J Gastrointest Surg; 1997; 1(4):362-9; discussion 370. PubMed ID: 9834371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulatory and diuretic effects of dopexamine infusion in low-birth-weight infants with respiratory failure.
    Kawczynski P; Piotrowski A
    Intensive Care Med; 1996 Jan; 22(1):65-70. PubMed ID: 8857441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous dopexamine in the treatment of acute congestive heart failure: results of a multicenter, double-blind, placebo-controlled withdrawal study.
    Asanoi H; Sasayama S; Sakurai T; Lee JD; Kinoshita M; Ishimura T; Yoshikawa J; Mitsudo K; Sato H; Morioka S
    Cardiovasc Drugs Ther; 1995 Dec; 9(6):791-7. PubMed ID: 8850384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood concentrations of dopexamine in patients during and after orthotopic liver transplantation.
    Gray PA; Jones T; Park GR
    Br J Clin Pharmacol; 1994 Jan; 37(1):89-92. PubMed ID: 8148227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers.
    Mousdale S; Clyburn PA; Mackie AM; Groves ND; Rosen M
    Br J Clin Pharmacol; 1988 May; 25(5):555-60. PubMed ID: 3408636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
    Svenson G; Strandberg LE; Lindvall B; Erhardt L
    Br Heart J; 1988 Dec; 60(6):489-96. PubMed ID: 3224052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopexamine hydrochloride, a novel drug with renal vasodilator properties: two case studies.
    Bodenham AR; Park GR
    Intensive Care Med; 1988; 14(6):663-5. PubMed ID: 3183194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.
    Murphy JJ; Hampton JR
    Br Heart J; 1988 Jul; 60(1):45-9. PubMed ID: 2900644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Uptake1 by dopexamine hydrochloride in vitro.
    Mitchell PD; Smith GW; Wells E; West PA
    Br J Pharmacol; 1987 Oct; 92(2):265-70. PubMed ID: 2890392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
    Magrini F; Foulds R; Roberts N; Macchi G; Mondadori C; Zanchetti A
    Eur J Clin Pharmacol; 1987; 32(1):1-4. PubMed ID: 2884113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
    Meinertz T; Drexler H; Just H
    Basic Res Cardiol; 1989; 84 Suppl 1():177-86. PubMed ID: 2573340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dopexamine, a new dopamine analogue, on platelet function in stress.
    Wagaine-Twabwe D; Hendra TJ; Smith CC; Yudkin JS
    Br J Clin Pharmacol; 1990 Jul; 30(1):87-95. PubMed ID: 2390435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New dopamine receptor agonists in heart failure and hypertension. Implications for future therapy.
    Horn PT; Murphy MB
    Drugs; 1990 Oct; 40(4):487-92. PubMed ID: 1982088
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
    Fitton A; Benfield P
    Drugs; 1990 Feb; 39(2):308-30. PubMed ID: 1970288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
    Dawson JR; Thompson DS; Signy M; Juul SM; Turnbull P; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1985 Sep; 54(3):313-20. PubMed ID: 4041300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.
    Jaski BE; Wijns W; Foulds R; Serruys PW
    Br J Clin Pharmacol; 1986 Apr; 21(4):393-400. PubMed ID: 2871852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
    Jaski BE; Peters C
    Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.